To determine the degree to which the breast cancer cell lines MCF-7 and MDA-MB-231 responded to the LPS treatment, we treated these cells with LPS and measured the expressions of the COX-2 and IL-6 genes in both cell lines. Here, IL6 is linked to breast carcinoma.